Ready to test your knowledge and enhance your skills in managing limited-stage small cell lung cancer (LS-SCLC)? Join us in this interactive Booster Quiz to explore cutting-edge updates and practical strategies for integrating immunotherapy into clinical practice. Discover the therapeutic rationale for immunotherapy in LS-SCLC, evaluate critical efficacy and safety data from key trials, and refine your approach to managing immune-related adverse events.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/latest-clinical-evidence-immunotherapy-small-cell-lung-cancer-booster-quiz-on
- Start Date: 2024-12-20 06:00:00
- End Date: 2024-12-20 06:00:00
- Credit Details: IPCE Credits: 0.25 hours
AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: AstraZeneca (Any division) - Amount: 35000.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest